57,58 Cystatin C-based eGFR (eGFRcys) is increasingly being adopted for detecting and staging CKD
(2019) 220:567.e1.e18
When the opportunity arose in 2020 to join Lilly and work in the early-phase group that brings new molecules forward to be tested as potential treatments for obesity and diabetes, I decided to take it
When protein hits your digestive tract, it stimulates insulin secretion and promotes GLP-1 output at the same time, a double benefit for blood sugar stability
Research suggests compounds like berberine and certain probiotics may influence metabolic health and pathways associated with GLP-1, though overall evidence is emerging and not equivalent to pharmaceutical GLP-1 agonist trials
(4) Metabolite synergy: BBR metabolites (berberrubine (BBB), palmatine (PMT)) reverse obesity-associated Akt pathway inhibition, ameliorating cell death, oxidative stress and mitochondrial dysfunction in HFD-fed mice [164]